We provide clients with expert assistance in clinical trial and drug development, protocol design, review of clinical trial data and management of adverse hematologic events.
Welcome to Catlett Hematology Advisory Services
Catlett Hematology Advisory Services (CHAS) offers consultations for a variety of issues and works closely with its clients to find answers to crucial questions, develop promising therapies, and achieve successful outcomes.
Our consulting company maintains a high level of expertise in the evolving knowledge of basic science, potential therapeutic targets, and advances in the diagnosis and treatment of hematologic diseases.
Dr. Joseph Catlett, founding and managing member of Catlett Hematology Advisory Services, a limited liability company, has over thirty years of experience in the research and treatment of both benign and malignant hematologic disorders.
CHAS is strategically located in the District of Columbia, close to the U. S. Food and Drug Administration, the National Institutes of Health, and several major academic centers.
With over thirty years of clinical experience, CHAS offers hematologic expertise for the following:
Guidance during design and conduct of clinical trials
Protocol review for appropriateness of objectives, clinically meaningful endpoints and monitoring during treatment
Review of data for hematologic safety signals
Advice regarding adverse event detection and mitigation strategies
Assistance with medico-legal issues (CHAS does not offer ‘expert witness’ services)
Input for forensic cases